World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking National Ranking Publications Citations
Immunology 58 3518 22 288 12210

Michael Feldman publications per year

The chart shows the history of publications by Michael Feldman between 1956 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael Feldman published across 70 years, from 1956 to 2025, averaging 4.6 papers a year. Output peaked at 18 publications in 1971. 19 of the 324 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1956 to 2025. Vertical axis: number of publications, 0 to 18. Peak 18 publications in 1971. 1956: 2 publications 1957: 2 publications 1958: 4 publications 1959: 2 publications 1960: 1 publication 1961: 1 publication 1962: 1 publication 1963: 1 publication 1964: 5 publications 1965: 5 publications 1966: 0 publications 1967: 4 publications 1968: 3 publications 1969: 9 publications 1970: 5 publications 1971: 18 publications 1972: 7 publications 1973: 7 publications 1974: 8 publications 1975: 12 publications 1976: 15 publications 1977: 4 publications 1978: 6 publications 1979: 18 publications 1980: 7 publications 1981: 10 publications 1982: 18 publications 1983: 18 publications 1984: 7 publications 1985: 6 publications 1986: 12 publications 1987: 4 publications 1988: 7 publications 1989: 4 publications 1990: 2 publications 1991: 3 publications 1992: 4 publications 1993: 9 publications 1994: 3 publications 1995: 5 publications 1996: 2 publications 1997: 3 publications 1998: 6 publications 1999: 4 publications 2000: 3 publications 2001: 0 publications 2002: 1 publication 2003: 0 publications 2004: 4 publications 2005: 1 publication 2006: 4 publications 2007: 0 publications 2008: 3 publications 2009: 0 publications 2010: 0 publications 2011: 0 publications 2012: 1 publication 2013: 0 publications 2014: 0 publications 2015: 1 publication 2016: 0 publications 2017: 0 publications 2018: 0 publications 2019: 0 publications 2020: 0 publications 2021: 0 publications 2022: 7 publications 2023: 6 publications 2024: 6 publications 2025: 13 publications
1956 2025

324 publications in total across all disciplines

View publications per year as a table
Michael Feldman: publications per year, 1956 to 2025
Year Publications
1956 2
1957 2
1958 4
1959 2
1960 1
1961 1
1962 1
1963 1
1964 5
1965 5
1966 0
1967 4
1968 3
1969 9
1970 5
1971 18
1972 7
1973 7
1974 8
1975 12
1976 15
1977 4
1978 6
1979 18
1980 7
1981 10
1982 18
1983 18
1984 7
1985 6
1986 12
1987 4
1988 7
1989 4
1990 2
1991 3
1992 4
1993 9
1994 3
1995 5
1996 2
1997 3
1998 6
1999 4
2000 3
2001 0
2002 1
2003 0
2004 4
2005 1
2006 4
2007 0
2008 3
2009 0
2010 0
2011 0
2012 1
2013 0
2014 0
2015 1
2016 0
2017 0
2018 0
2019 0
2020 0
2021 0
2022 7
2023 6
2024 6
2025 13
Total 324
Download as CSV

Michael Feldman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Feldman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 282–291 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 288 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115 288
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Michael Feldman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Feldman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 58–59 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201 58
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Michael Feldman was affiliated with the Weizmann Institute of Science in Israel. Their research spanned multiple domains within medicine and economics, particularly focusing on oncology and health economics.

Their work included multiple studies on cancer screening, diagnostics, and economic evaluations in health care. Fields of study covered by the scientist were primarily Medicine and Economics, Econometrics and Finance. Subfields reflected this interdisciplinary approach with publications in Oncology, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Genetics, and Cancer Research.

Research topics explored by Michael Feldman encompassed:

  • Colorectal Cancer Screening and Detection
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life
  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Diabetes Treatment and Management
  • Diabetes Management and Research

Frequent co-authors included Ali Tafazzoli (10 publications), Karen Chung (8), A. Mark Fendrick (8), Ameya Chavan (6), and Odette S. Reifsnider (5). The scientist's publications appeared often in journals such as Value in Health (7 publications), Journal of the National Comprehensive Cancer Network (4), Annals of Oncology (2), The American Journal of Managed Care (2), and Cancer Epidemiology Biomarkers & Prevention (2).

Recent papers published by Michael Feldman include:

  • Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK (2021, British Journal of Cancer)
  • Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial (2021, American Journal of Kidney Diseases)
  • Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests (2022, Patient)
  • The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA (2022, PharmacoEconomics)
  • Health state utility values by cancer stage: a systematic literature review (2021, The European Journal of Health Economics)

Best Publications

  • Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

    D Zagury;J Bernard;R Leonard;R Cheynier

  • Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

    R. Wallich;N. Bulbuc;G. J. Hämmerling;S. Katzav

  • HTLV-III in cells cultured from semen of two patients with AIDS

    D Zagury;J Bernard;J Leibowitch;B Safai

  • CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

    Ofer Mandelboim;Gideon Berke;Mati Fridkin;Michael Feldman

  • Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells

    Angel Porgador;Esther Tzehoval;Anne Katz;Ezra Vadai

  • C-C Chemokines, Pivotal in Protection Against HIV Type 1 Infection

    Daniel Zagury;Abderrahim Lachgar;Vida Chams;Lat S. Fall

  • Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS

    Daniel Zagury;Abderrahim Lachgar;Vida Chams;Lat S. Fall

  • Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

    Ofer Mandelboim;Ezra Vadai;Mati Fridkin;Anne Katz-Hillel

  • Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level

    D. Zagury;Jacky Bernard;Noelle Thierness;M. Feldman

  • Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties

    Patrick De Baetselier;Shulamit Katzav;Eliezer Gorelik;Michael Feldman

  • Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

    A. Porgador;Rajat Bannerji;Y. Watanabe;M. Feldman

  • THE FORMATION OF HYBRID MULTINUCLEATED MUSCLE FIBERS FROM MYOBLASTS OF DIFFERENT GENETIC ORIGIN.

    David Yaffe;Michael Feldman

  • Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumor

    A. J. Treves;C. Carnaud;N. Trainin;M. Feldman

  • MHC imbalance and metastatic spread in Lewis lung carcinoma clones

    Lea Eisenbach;Shraga Segal;Michael Feldman

  • Antigenic Specificity of Benzo[a]pyrene-Induced Sarcomas

    Amiela Globerson;Michael Feldman

  • The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

    Lea Eisenbach;Nurit Hollander;Lea Greenfeld;Hadas Yakor

  • Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor

    Mina Fogel;Eliezer Gorelik;Shraga Segal;Michael Feldman

  • Differences in Resistance of Metastatic Tumor Cells and Cells From Local Tumor Growth to Cytotoxicity of Natural Killer Cells

    Eliezer Gorelik;Mina Fogel;Michael Feldman;Shraga Segal

  • Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cells

    Angel Porgador;Bernd Gansbacher;Rajat Bannerji;Esther Tzehoval

  • Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.

    E Tzehoval;S Segal;Y Stabinsky;M Fridkin

  • The frequency of effector cells in populations containing cytotoxic T lymphocytes

    G. Berke;D. Gabison;M. Feldman

Frequent Co-Authors

Shraga Segal
Shraga Segal Ben-Gurion University of the Negev
Irun R. Cohen
Irun R. Cohen Weizmann Institute of Science
Mati Fridkin
Mati Fridkin Weizmann Institute of Science
Gideon Berke
Gideon Berke Weizmann Institute of Science
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
David Yaffe
David Yaffe Weizmann Institute of Science
Jean-François Zagury
Jean-François Zagury heSam Université
Michel Revel
Michel Revel Weizmann Institute of Science
Michael Sela
Michael Sela Weizmann Institute of Science
Leo Sachs
Leo Sachs Weizmann Institute of Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens opportunities not only within research and healthcare but also through complementary nursing and clinical programs. For those interested in advancing quickly, exploring the easiest absn programs to get into can be a strategic route. These programs offer accelerated pathways for registered nurses to earn bachelor’s degrees and expand their career options.

Entry-level nursing roles related to immunology careers can often begin with practical experience gained through programs identified as which lpn programs are easiest to get into. Licensed Practical Nurse programs provide foundational clinical skills applicable in immunology-focused healthcare settings.

For nurses aiming to specialize further, the easiest online nurse practitioner programs provide flexible, accessible options to gain advanced clinical training, often necessary for immunology-related patient care and treatment roles.

Additionally, mental health considerations are vital in immunology research and treatment. Prospective students should consider pmhnp programs online with best clinical placement, which focus on psychiatric mental health nursing and offer strong clinical practicum experiences to enhance care competencies.

Best Scientists Citing Michael Feldman

Recently Published Articles